Business Description
![Viracta Therapeutics Inc Viracta Therapeutics Inc logo](https://static.gurufocus.com/logos/0C0000C29B.png?14)
Viracta Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US92765F1084
Description
Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein-Barr virus-positive lymphoma. The product candidate of the company is a combination product candidate consisting of nanatinostat, a potent and selective small molecule inhibitor of class I histone deacetylases (HDAC), and valganciclovir, an FDA-approved anti-viral drug used to treat and prevent disease caused by a virus called cytomegalovirus (CMV) in people with organ transplants.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.1 | |||||
Equity-to-Asset | 0.27 | |||||
Debt-to-Equity | 1.7 | |||||
Debt-to-EBITDA | -0.43 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -33.7 | |||||
3-Year EPS without NRI Growth Rate | -36.9 | |||||
3-Year FCF Growth Rate | -33.5 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 64.9 | |||||
9-Day RSI | 50.3 | |||||
14-Day RSI | 44.64 | |||||
6-1 Month Momentum % | 13.55 | |||||
12-1 Month Momentum % | -53.53 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.35 | |||||
Quick Ratio | 1.35 | |||||
Cash Ratio | 1.31 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.9 | |||||
Shareholder Yield % | -41.5 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -158.59 | |||||
ROA % | -73.36 | |||||
ROIC % | -304.56 | |||||
ROC (Joel Greenblatt) % | -7842.3 | |||||
ROCE % | -113.51 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 3.79 | |||||
Price-to-Tangible-Book | 3.79 | |||||
EV-to-EBIT | -0.13 | |||||
EV-to-EBITDA | -0.13 | |||||
EV-to-FCF | -0.16 | |||||
Price-to-Net-Current-Asset-Value | 4.08 | |||||
Price-to-Net-Cash | 2.21 | |||||
Earnings Yield (Greenblatt) % | -769.23 | |||||
FCF Yield % | -174.55 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:VIRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Viracta Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -1.23 | ||
Beta | 0.36 | ||
Volatility % | 84.9 | ||
14-Day RSI | 44.64 | ||
14-Day ATR ($) | 0.053612 | ||
20-Day SMA ($) | 0.535605 | ||
12-1 Month Momentum % | -53.53 | ||
52-Week Range ($) | 0.43 - 1.68 | ||
Shares Outstanding (Mil) | 39.27 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Viracta Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Viracta Therapeutics Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Viracta Therapeutics Inc Frequently Asked Questions
What is Viracta Therapeutics Inc(VIRX)'s stock price today?
The current price of VIRX is $0.53. The 52 week high of VIRX is $1.68 and 52 week low is $0.43.
When is next earnings date of Viracta Therapeutics Inc(VIRX)?
The next earnings date of Viracta Therapeutics Inc(VIRX) is 2024-08-14 Est..
Does Viracta Therapeutics Inc(VIRX) pay dividends? If so, how much?
Viracta Therapeutics Inc(VIRX) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |